In the large, international, PRESENT observational study, the average baseline HbA1c in patients receiving basal insulin (analogue or human) was greater than 9.3% (10), possibly at least in part because of impairment of the second phase insulin release resulting from β-cell glucotoxicity as diabetes progresses (4). Here, INS is linked to diabetes mellitus.